Clinical Features of 294 Turkish Patients with Chronic Myeloproliferative Neoplasms

Creative Commons License

ANDIÇ N., ÜNÜBOL M., Yagci E., Akay O. M., YAVAŞOĞLU İ., KADIKÖYLÜ V. G., ...More

TURKISH JOURNAL OF HEMATOLOGY, vol.33, no.3, pp.187-195, 2016 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 33 Issue: 3
  • Publication Date: 2016
  • Doi Number: 10.4274/tjh.2015.0041
  • Journal Name: TURKISH JOURNAL OF HEMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.187-195
  • Keywords: Myeloproliferative neoplasms, Survival, Thrombosis, Treatment, TYROSINE KINASE JAK2, ESSENTIAL THROMBOCYTHEMIA, POLYCYTHEMIA-VERA, RISK-FACTORS, PROGNOSTIC-FACTORS, LIFE EXPECTANCY, THROMBOSIS, MYELOFIBROSIS, MUTATION, HYDROXYUREA
  • Open Archive Collection: AVESIS Open Access Collection
  • Eskisehir Osmangazi University Affiliated: Yes

Abstract

Objective: Myeloproliferative neoplasms (MPNs) share common clonal stem cells but show significant differences in their clinical courses. The aim of this retrospective study was to evaluate thrombotic and hemorrhagic complications, JAK2 status, gastrointestinal and cardiac changes, treatment modalities, and survival in MPNs in Turkish patients.